KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVS) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to 0.22%.

  • Novartis Ag's Return on Capital Employed rose 200.0% to 0.22% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.22%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.22% for FY2025, which is 200.0% up from last year.
  • Novartis Ag's Return on Capital Employed amounted to 0.22% in Q4 2025, which was up 200.0% from 0.24% recorded in Q3 2025.
  • Novartis Ag's Return on Capital Employed's 5-year high stood at 0.24% during Q3 2025, with a 5-year trough of 0.1% in Q4 2022.
  • In the last 5 years, Novartis Ag's Return on Capital Employed had a median value of 0.12% in 2021 and averaged 0.15%.
  • Per our database at Business Quant, Novartis Ag's Return on Capital Employed plummeted by -200bps in 2022 and then skyrocketed by 700bps in 2024.
  • Novartis Ag's Return on Capital Employed (Quarter) stood at 0.12% in 2021, then decreased by -20bps to 0.1% in 2022, then increased by 26bps to 0.12% in 2023, then skyrocketed by 60bps to 0.2% in 2024, then grew by 10bps to 0.22% in 2025.
  • Its last three reported values are 0.22% in Q4 2025, 0.24% for Q3 2025, and 0.24% during Q2 2025.